Alterations in Sympathetic Ganglionic Transmission in Response to Angiotensin II in (mRen2)27 Transgenic Rats

Hypertension

Volumn 43, Issue 2 I, 2004, Pages 270-275

  Aileru, Azeez A ^a   Logan, Exazevia ^b   Callahan, Michael ^b   Ferrario, Carlos M ^b   Ganten, Detlev ^c   Diz, Debra I ^b  

^a WINSTON SALEM STATE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiotensin II; Arterial; Autonomic nervous system; Hypertension; Rats, transgenic; Receptors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; IODINE 125; RECEPTOR SUBTYPE;

ADRENERGIC ACTIVITY; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERTENSION; ISOTOPE LABELING; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PARAMETER; POST TETANIC POTENTIATION; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SUPERIOR CERVICAL GANGLION; SYMPATHETIC GANGLION; TRANSGENIC ANIMAL;

ANGIOTENSIN II; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTORADIOGRAPHY; GANGLIA, SYMPATHETIC; HYPERTENSION; MICE; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN; SYNAPTIC TRANSMISSION;

EID: 0842289421     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000112422.81661.f3     Document Type: Article

References (47)

1. 3) receptors. J Physiol (Lond). 1996;496:479-489.
2. Brown DA, Dunn PM. Depolarization of rat isolated superior cervical ganglia mediated by beta 2-adrenoceptors. Br J Pharmacol. 1983;79:429-439.
3. Libet B, Kobayashi H, Tanaka T. Synaptic coupling into the production and storage of a neuronal memory trace. Nature. 1975;258:155-157.
4. Weinreich D, Undem BJ, Taylor G, Barry MF. Antigen-induced long-term potentiation of nicotinic synaptic transmission in the superior cervical ganglion of the guinea pig. J Neurophysiol. 1995;73:2004-2016.
5. Kuba K, Kmamoto E. Long-term potentiation of transmitter release induced by adrenaline in bull-frog sympathetic ganglia. J Physiol (Lond). 1986;374:515-530.
6. Dun NJ, Jiang ZG, Mo N. Long-term facilitation of peptidergic transmission by catecholamines in guinea pig inferior mesenteric ganglia. J Physiol (Lond). 1994;357:37-50.
7. Aileru AA, De Albuquerque A, Hamlyn JM, Manunta P, Shah JR, Hamilton MJ, Weinreich D. Synaptic Plasticity in Sympathetic ganglia from acquired and inherited forms of ouabain-dependent hypertension. Am J Physiol (Regul Integra Comp Physiol). 2001;281:R635-R644.
8. Magee JC, Schofield GG. Neurotransmission through sympathetic ganglia of spontaneously hypertensive rats. Hypertension. 1992;20:367-373.
9. Yarowsky P, Weinreich D. Loss of accommodation in sympathetic neurons from spontaneously hypertensive rats. Hypertension. 1985;7:268-276.
10. Magee JC, Schofield GG. Alterations of sympathetic transmission in sympathetic ganglia of spontaneously hypertensive rats. Am J Physiol (Regul Integra Comp Physiol). 1994;267:R1397-R1407.
11. Anderson EA, Sinkley CA, Lawton WI, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
12. Bunag RD, Teravainen T-L. Sympathetic hyperresponsiveness to thalamic stimulation in young hypertensive rats. Am J Physiol (Regul Integra Comp Physiol). 1979;237:R39-R44.
13. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension. 1991;17:III29-III35.
14. Huang BS, Leenen FH. Sympatheoexicitatory and pressor responses to increased brain sodium and ouabain are mediated via brain angiotensin II. Am J Physiol (Heart Circ Physiol). 1996;270:H275-H280.
15. Koepke JP, Jones S, DiBona GF. Alpha2-adrenoceptors in amygdala control renal sympathetic nerve activity and renal function in conscious spontaneously hypertensive rats. Brain Res. 1987;404:80-88.
16. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens. 1996;14: S159-S165.
17. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest. 1993;92:25-28.
18. Miyajima E, Yamada Y, Yoshida Y, Masukawa T, Shionoiri H, Tochikubo O, Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension. 1991;17:1057-1062.
19. Schobel HP, Fisher T, Hewszer K, Geiger H, Schmieder RE. Preeclampsia: a state of sympathetic overactivity. N Engl J Med. 1996;335:1480-1485.
20. Ma X, Chapleau MW, Whiteis CA, Abboud FM, Bielefeldt K. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice. Circ Res. 2001;88:787-793.
21. Lewis GP, Reit E. Further studies on the actions of peptides on the superior cervical ganglion and suprarenal medulla. Brit J Pharmacol. 1966;26:444-460.
22. Ganten D, Lindpaintner K, Ganten U, Peters J, Zimmermann F, Bader M, Mullins J. Transgenic rats: new animal models in hypertension research. Hypertension. 1991;17:843-855.
23. Kollai M, Koizumi K. Cardiovascular reflexes and interrelationships between sympathetic and parasympathetic activity. J Autonom Nerv Sys. 1981;4:135-148.
24. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995;25:1260-1265.
25. Diz DI, Westwood B, Bosch SM, Ganten D, Ferrario C. NKI receptor antagonist blocks angiotensin II responses in renin transgenic rat medulla oblongata. Hypertension. 1998;31:473-479.
26. Bunag RD, Teravainen T-L. Tail-cuff detection of systolic hypertension in different strains of aging rats. Mech Ageing Dev. 1991;59:197-213.
27. Allred AJ, Chappell MC, Ferrario CM, Diz DI. Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol (Renal Physiol). 2000;279:F636-F645.
28. Chappell MC, Diz DI, Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides. 1992;13:313-318.
29. 1 receptors in neointima of rat carotid artery and aorta after ballon catheter injury. Peptides. 1994;15:1205-1212.
30. Goldfarb DA, Diz DI, Tubbs RR, Ferrario CM, Novick AC. Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urology. 1994;151:206-213.
31. Wu RL, McKenna DGMDA. Age-related changes in the synaptic plasticity of rat superior cervical ganglia. Brain Res. 1991;543:324-329.
32. Briggs CA, Brown TH, McAfee DA. Neurophysiology and pharmacology of long-term potentiation in the rat sympathetic ganglion. J Physiol (Lond). 1985;359:503-521.
33. Averill DB, Brady M, Eyler E, Ganten D, Ferrario CM. MRen-2 transgenic rats have reduced sympathetic vascular response. Soc Neurosci Abstr. 1996;22:854.
34. Briggs CA, McAfee DA. Long-term potentiation at nicotinic synapses in the rat superior cervical ganglion. J Physiol (Lond). 1988;404:129-144.
35. Li P, Morris M, Diz DI, Ferrario CM, Ganten D, Callahan MF. Role of paraventricular angiotensin AT-1 receptors in salt sensitive hypertension in mRen-2 transgenic rats. Am J Physiol (Regul Integra Comp Physiol). 1996;270:R1178-R1181.
36. Jackson L, Sakima A, Oden SD, Tommasi EN, Ganten D, Ferrario CM, Diz DI. Angiotensin receptor density in dorsomedial medulla under varying local angiotensin levels during aging. Proceedings of the XVth Scientific Meeting of the Inter-Am Society of Hypertension. American Heart Association; 2003:31 (abstract).
37. Diz DI, Jessup JA, Westwood BM, Bosch SM, Vinsant S, Gallagher PE, Averill DB. Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin Exper Pharmacol Physiol. 2001;29:473-482.
38. Diz DI, Falgui B, Bosch SM, Westwood BM, Kent J, Ganten D, Ferrario CM. Hypothalamic substance P release: attenuated angiotensin responses in mRen2(27) transgenic rats. Hypertension. 1997;29:510-513.
39. Halbach OV, Albrecht D. Angiotensin II inhibits long-term potentiation within the lateral nucleus of the amygdala through AT(1) receptors. Peptides. 1998;19:1031-1036.
40. Wayner MJ, Phelix CF, Armstrong DL. Lateral hypothalamic stimulation inhibits dentate granule cell LTP: direct connections. Research Bulletin. 1997;43:5-15.
41. Wayner MJ, Armstrong DL, Phelix CF. Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides. 2001;22:1403-1414.
42. Pinto JEB, Nazarali AJ, Saavedra JM. Angiotensin II binding sites in the superior cervical ganglia of spontaneously hypertensive and Wistar-Kyoto rats after preganglionic denervation. Brain Res. 1988;475:146-150.
43. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
44. Strauss HM, Mrowka R, Nafz B, Patzak A, Unger T, Persson PB. Does low frequency power of arterial blood pressure reflect sympathetic tone? J Autonomic Nervous System. 1995;54:145-154.
45. Li P, Morris M, Ferrario CM, Barrett C, Ganten D, Callahan MF. Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats. Amer J Physiol (Heart and Circulatory). 1999;275:H1130-H1137.
46. Schiffer S, Pummer S, Witte K, Lemmer B. Cardiovascular regulation in tgr(mren2)27 rats: 24h variation in plasma catecholamines, angiotensin peptides, and telemetric heart rate variability. Chronobiol Int. 2001;18:461-474.
47. Averill DB, Matsumura K, Ganten D, Ferrario CM. Role of area postrema in transgene hypertension. Hypertension. 1996;27:591-597.